Dassault Systemes vs Fair Isaac: why the prices moved differently

• ▲

  ArisGlobal acquisition expands life-sciences AI platform Dassault agreed to buy ArisGlobal, a drug-safety and compliance software firm, for about $1.8 billion plus up to $200 million in milestone payments. ArisGlobal serves over 200 customers and half of the top 50 biopharma companies, deepening Dassault's life-sciences reach and adding recurring revenue.

  This is the period's biggest strategic move, directly expanding a key growth business and supporting future revenue.

• ▲

  Q2 results solid, full-year targets confirmed Dassault reported Q2 revenue up 4% at constant currencies to €1.56 billion, with subscription revenue up 8% and cloud and 3DEXPERIENCE software each up 14%. Operating margin was 30.0% and earnings per share rose 8%. Management confirmed full-year targets, signaling steady demand.

  Solid results and confirmed guidance underpin investor confidence in the company's core business.

• ▲

  New AI products launched across Medidata and 3DEXPERIENCE Medidata launched Medidata Plus, an AI layer for clinical trials, with dozens of customers in talks. Dassault also released Virtual Companions AURA, LEO and MARIE on its 3DEXPERIENCE platform. These AI tools aim to speed workflows and deepen customer lock-in.

  Shows Dassault is monetizing AI across its key franchises, a potential driver of future growth.

• ▲

  Semiconductor digital twin partnership with Silvaco Silvaco and Dassault will link Silvaco's process simulation with Dassault's SIMULIA tools to create digital twin workflows for chip manufacturing. The partnership extends SIMULIA into semiconductor fabrication, a large new market, and could open additional revenue streams.

  A new partnership that broadens Dassault's simulation reach into semiconductors, supporting long-term growth.

Based on 6 stories →

• ▼

  FHFA ends FICO's mortgage scoring exclusivity The Federal Housing Finance Agency approved VantageScore 4.0 for all Fannie Mae and Freddie Mac loans, ending FICO's long-held monopoly in mortgage credit scoring. This introduces direct competition, threatening FICO's market share and pricing power. The stock fell sharply on the news.

  This is the core new event that directly threatens FICO's mortgage scoring business and triggered the stock decline.

• ▼

  Unified pricing grid lets VantageScore bypass FICO FHFA will consolidate Fannie and Freddie pricing into one grid that includes VantageScore, allowing lenders to use VantageScore for loan-level pricing and approval without FICO. This removes FICO's fee leverage and could accelerate share loss.

  This structural change intensifies competition and directly undermines FICO's ability to charge premium fees.

• ▼

  Potential bi-merge requirement adds pressure FHFA may require lenders to use only two credit bureaus instead of three for mortgages sold to Fannie and Freddie. This could reduce demand for traditional tri-merge reports and further weaken FICO's position, as it may favor VantageScore.

  This is a new regulatory threat that compounds the competitive pressure on FICO's mortgage scoring business.

• ▲

  FICO launches direct license program; regulator not targeting FICO FICO launched a Mortgage Direct License Program and FHFA Director Pulte signaled he is not purposefully targeting the company. This provided a slight reprieve, but the overall competitive and regulatory threats remain dominant.

  This is a new positive development that offers some counterbalance to the negative news, though it does not reverse the competitive threat.

Based on 6 stories →

• ▲

  FICO Score 10T embedded in Optimal Blue FICO's new mortgage score is now built into Optimal Blue, the platform used by most big U.S. mortgage lenders. That makes FICO harder to replace and should keep demand strong, supporting the stock price over time.

  This is a new event that strengthens FICO's competitive position and future revenue.

• ▲

  Record Q3 profit and raised guidance FICO reported record quarterly revenue of $674 million, up 26%, and profit jumped 41% per share. It raised its full-year outlook, citing a better mortgage market. Strong results and higher guidance push the stock up.

  This is the core new financial result that directly moves the stock.

• ▼

  Revenue miss and delayed Direct Licensing Program Despite record profit, revenue fell short of analyst estimates, and FICO delayed its Direct Licensing Program. That delay and the miss disappointed investors, sending shares down sharply. The market worries about future growth timing.

  This is the main new negative event that caused the stock to drop.

• ▼

  FHFA rule opens mortgage scoring to a lower-cost rival A new FHFA rule allows a cheaper competitor into mortgage scoring, threatening FICO's pricing power in its biggest market. This regulatory pressure is a real counterweight, keeping a lid on the stock even as profits grow.

  This is a new regulatory threat that could erode FICO's long-term cash flow.

Based on 7 stories →